SCHEMBL18696282

SCHEMBL18696282

FC(F)(F)Oc1ccc(NC2NC=Nc3nn(Cc4cccc(Br)c4)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.36
BCR P11274 2/20 0.36
F2RL3 Q96RI0 1/20 0.34
KCNH2 Q12809 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNA1I Q9P0X4 1/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
TP53 P04637 2/20 0.33
ROCK2 O75116 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KLKB1 P03952 1/20 0.31
EPHX2 P34913 1/20 0.31
PPARA Q07869 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
RECQL P46063 1/20 0.31
HDAC1 Q13547 2/20 0.31
AADAT Q8N5Z0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16374017 0.80 ABL1 (0.46) ABL1BCRCYP3A4CYP2C9TP53
SCHEMBL29699885 0.70 TP53 (0.52) ABL1KCNH2CACNA1GCACNA1HCACNA1I
SCHEMBL29699941 0.69 TP53 (0.47) ABL1KCNH2CACNA1GCACNA1HCACNA1I
SCHEMBL3400748 0.69 ABL1 (0.73) ABL1BCR
SCHEMBL29699853 0.68 TP53 (0.50) ABL1KCNH2CACNA1GCACNA1HCACNA1I
SCHEMBL29699842 0.64 CYP3A4 (0.65) ABL1KCNH2CYP3A4CYP2C9TP53
SCHEMBL15504901 0.64 SMN1; SMN2 (0.52) ABL1KCNH2CYP3A4CYP2C9TP53
SCHEMBL30370406 0.62 SLC6A4 (0.46)
SCHEMBL15504917 0.61 MAPT (0.65) ABL1KCNH2CYP2C9TP53SMN1; SMN2
SCHEMBL13070020 0.61 MBTD1 (0.51) ABL1KCNH2SMN1; SMN2ALDH1A1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912973-A2 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE Dana-Farber Cancer Institute, Inc. (US) 2021-11-24 EP disclosed
EP-3536687-A1 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE Dana Farber Cancer Institute, Inc. (US) 2019-09-11 EP disclosed
EP-3150593-A1 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE Dana Farber Cancer Institute, Inc. (US) 2017-04-05 EP disclosed